Showing posts with label Congenital Insensitivity to Pain. Show all posts
Showing posts with label Congenital Insensitivity to Pain. Show all posts

Friday, August 24, 2012

Physiology of Nav1.7

Physiology of Nav1.7
In sensory neurons, multiple voltage-dependent sodium currents can be differentiated by their gating kinetics and voltage dependence and can also be defined by their sensitivity to the voltage gated sodium-channel blocker tetrodotoxin. The Nav1.7 channel produces a rapidly activating and inactivating current that is sensitive to submicromolar levels of tetrodotoxin. This is in contrast with Nav1.8, which is also present within DRG neurons but is fairly resistant to tetrodotoxin. Nav1.7 appears to be important in early phases of neuronal electrogenesis. Nav1.7 is characterized by slow transition of the channel into an inactive state when it is depolarized, even to a minor degree, a property that allows these channels to remain available for activation with small or slowly developing depolarizations, usually mimicked by electrophysiologists as ramp-like stimuli. Thus, Nav1.7 acts as a “threshold channel” that amplifies small, subtle depolarizations such as generator potentials, thereby bringing neurons to voltages that stimulate Nav1.8, which has a more depolarized activation threshold and which produces most of the transmembrane current responsible for the depolarizing phase of action potentials. In this regard, Nav1.7 is poised as a molecular gatekeeper of pain detection at peripheral nociceptors.

Thursday, August 23, 2012

Sodium channels

Sodium channels

Voltage-gated sodium channels play a critical role in the generation and conduction of action potentials — so important for electrical signalling by most excitable cells. Sodium channels are integral membrane proteins and are comprised of a large α subunit, which forms the voltage-sensitive and ion-selective pore, and smaller auxiliary β subunit(s) that can modulate the kinetics and voltage dependence of channel gating. Till 2007, 9 isoforms of the sodium-channel α subunit (Nav1.1– Nav1.9), each with a unique central and peripheral nervous system distribution had been identified. 4 closely related sodium channels (Nav 1.1, -1.2, -1.3, and -1.7) are encoded by a set of 4 genes (SCN1A, SCN2A, SCN3A, and SCN9A, respectively) located within a cluster on chromosome 2q24.3. Mutations in the genes encoding Nav1.1, -1.2, and -1.3 are responsible for a group of epilepsy syndromes with overlapping clinical characteristics but divergent clinical severity, mutation in the gene encoding Nav1.7 has a critical role in pain sensation.

Nav1.7 is encoded by SCN9A, a 113.5-kb gene comprising 26 exons (OMIM 603415). he encoded sodium channel is composed of 1977 amino acids organized into 4 domains, each with 6 transmembrane segments, and is predominantly expressed in the dorsal root ganglion (DRG) neurons and sympathetic ganglion neurons.

Immunohistochemical studies show that Nav1.7 is present at the distal ends of the wire-like projections of neurons known as neuritis, close to the impulse trigger zone where neuronal firing is initiated.


Interestingly, the large majority of DRG neurons that express Nav1.7 are pain sensing (nociceptive), suggesting a role for this sodium channel in the pathogenesis of pain. In addition to Nav1.7, Nav1.8 and Nav1.9 are also predominantly present in small nociceptive sensory neurons and the nerve fibres emanating from them.


Tuesday, August 21, 2012

Genetic Basis for Pain


The discovery of human genome allows comparing variations at the genetic level with inter-individual differences in pain thresholds and pain perception. Most studies in the past have focused on genetic polymorphisms that might be responsible for inter-individual differences in pain perception. Recently, genetic studies in families by James Cox and his team members, demonstrating recessively inherited CIP have identified nonsense mutations which result in truncation of the voltage-gated sodium channel type 1 x α subunit (SCN9A) — a 113.5 kb gene comprising 26 exons. The encoded sodium channel is composed of 1977 amino acids and is organised into 4 domains, each with 6 transmembrane segments. [Klugbauer et al. 1995]. The SCNA family of sodium channels (SCN1A-SCN11A) evolved from an archetypal potassium channel by quadruplicating, where 4 potassium subunits have to coalesce to form the functional potassium channel. SCN9A is predominantly expressed in the ‘dorsal root ganglion (DRG) neurons’ and sympathetic ganglion neurons. Functional studies, though performed for only some mutations to date, have shown that CIP associated mutations led to loss of function of Nav1.7.

Sunday, August 19, 2012

Body Parts Affected

What parts of the body does it affect?

It makes people with this condition feel no pain anywhere including the skin, deep tissues where special nociceptors called somatic pain are; and organs where the viceral pain nociceptors are. Because everything is surrounded by nerve endings to be managed by the brain, so everything feel pain, and is very dangerous in this condition that people don´t feel any pain, because they could die of an organ inflammation or some infection and they wouldn´t notice it.

Saturday, August 18, 2012

Cause


This autosomal recessive condition trait to chromosome 2q24.3. This region contains the gene SCN9A, encoding the α-subunit of the voltage gated sodium channel, Nav1.7, which is strongly expressed in nociceptive neurons. Sequence analysis of SCN9A in affected individuals revealed 3 distinct homozygous nonsense mutations:

ü W897X: Located in the P-loop of domain 2
ü 1767X: Located in the S2 segment of domain 2
ü S459X: Located in the linear region between 1 &2

This results in a truncated non-functional protein. Nav1.7 channels are expressed at high levels in nociceptive neurons of the ‘dorsal root ganglia’. As these channels are likely involved in the formulations and propagation of action potentials in such neurons, it is expected that loss of function mutation in SCN9A will lead to abolished nociceptive pain propagation.

Saturday, July 21, 2012

Types

Types on Congenital Pain Indifference (CIP)

Insensitivity to Pain means that the painful stimulus is not even perceived i.e. a patient cannot describe the intensity or the type of pain.

Indifference to Pain means that the patient can perceive the stimulus but lacks appropriate responses i.e. they will not flinch or withdraw when expose to pain.


Friday, July 20, 2012

Symptoms

Symptoms

For patents with this autosomal recessive disorder ‘Congenital Insensitivity to Pain (CIP)’ ‘Cognition’ and ‘Sensation’ are otherwise normal for example the patient can still feel discriminative touch (though not always temperature) and there is no detectable physical abnormalities.

Children with this condition often suffer oral cavity damage both in and around the oral cavity (such as having bitten of the tip of their tongue) or fractures to bones. Unnoticed infection and ‘corneal damage’ due to foreign objects in the eye are also found. Because the child can not feel pain they may not respond to problems, thus being at a higher risk of more severe disease or otherwise.

In some patients a mild intellectual disability as well as an impaired corneal reflect also noticed. 

Thursday, July 19, 2012

Difference between CIP & CIPA

Difference between Congenital Insensitivity to Pain (CIP) & Congenital Insensitivity to pain with Anhidrosis (CIPA)


The difference between CIP & CIPA is that in CIP the person only cant feel pain but in case of CIPA the person cannot sweat and probably has malformations in his/ her body.

Wednesday, July 18, 2012

CIP

What is Congenital Insensitivity to Pain (CIP)?

Congenital Insensitivity to Pain (CIP) also called Hereditary Sensory Automatic Neuropathy (HSAN) is a disease that affects the centry nerves that is caused by a genetic mutation that prevents the formation of nerve cells called nociceptors or axonicas endings also called pain nerves, that are specialized pain receptors to feel pressure, temperatures and stretching in and around their tissues. 

There is a similar kind of disease called Congenital Insensitivity to pain with Anhidrosis (CIPA) in which the nervous system prevents the sensation of pain, heat, cold or any real sensation with inability to sweat normally.

Tuesday, July 17, 2012

Historical Background


Reports of individual who appeared insensitive to pain from birth onwards have a long history but it was not until the 1930’s that this condition attracted medical attention.

The 1st case was reported by Dr. Dearborn in 1932 — he described his patient who acts as a human pincushion in a circus and crucifixion had to be called off when a woman in the audience fainted after a spike was driven through his one hand.

Initially, various terms were used to describe these individuals including ‘Congenital General Pure Analgesia’ (Dearborn, 1932), ‘Congenital Universal Insensitiveness to Pain’ (Ford & Wilkinsons, 1938), ‘Congenital Universal Indifference to Pain’ (Winkelmann et al., 1962). As these labels show, the phenomenon encompasses diverse abnormal responses to pain. Some patients have an absence of responses to injury, abnormal automatic responses to painful stimuli and difficulties in distinguishing various types of stimuli, whereas others exhibit lack of responsiveness to the stimuli but retain the ability to identify stimulus presence and mobility.

Over time 2 terms predominantly describe these individuals — ‘Congenital Insensitivity to Pain’ (McMurray 1950) and ‘Congenital Indifference to Pain’ (Jewesbury, 1970). Although the terms were often used interchangeably, only in recent years they have acquired distinct meanings and careful authors now to use them to distinguish two groups of individuals (Jewesbury, 1970; Landrieu et al., 1990).

Patients with congenital insensitivity pain seem not to perceive sensations of pain i.e. they have remarkably impaired ability to perceive the type, intensity and quality of painful stimuli. On the other hand, those with congenital indifference to pain, however, painful stimuli are perceived but there is an absence of the affective response to pain, rather than a lack of signal transmission. These individual reports experiencing sensations of pain but exhibit no aversion to or withdrawal from painful stimuli.

Monday, July 16, 2012

LIFE WITHOUT PAIN !!!!!


How would life if there is no pain? Don’t we thing a life without pain sounds great.

THINK AGAIN!!!

What happens if we do not feel pain?

WE SIMPLY CAN’T LIVE!!!

NO PAIN NO GAIN. Yes that’s true for our daily life also.

PAIN warns us that something is not right. Pain is body’s way of warning from impending injury and important defence mechanism in day to day life.
PAIN teaches children not to put their hands on hot plate because they know that heat hurts. It urges us to consult doctor when pain persists in any part of our body.

On the contrary what about pain that accompanies something which has already been diagnosed? What about the persistent pain that frequently escorts chronic conditions such as a sore back or cancer? Who can see the good/positivity in that kind of pain?

Though there may be instances when it seems superfluous and even cruel, the sensation of pain is more necessary that is not.

It is a clear indication that there is something wrong and that it needs to be seen to. In the absence of pain, no alert signals are given off—which could ultimately put our life in danger.

The sensation of pain is a complex sensation with many a meaning and many a pathway. One particular pathway was discovered when members of a family were incapable of feeling pain—a singular and rare condition due to the loss of functions of a protein known as ‘SCN9A’ or Nav1.7

The loss of function of SCN9A/Nav1.7 protein leads to a rare autosomal disease/disorder —‘Congenital Insensitivity to Pain’ — belongs to the family of Hereditary Sensory and Autonomic Neuropathies (HSAN).